Related Experiment Video
Updated: Jul 13, 2026
07:35
Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
Published on: December 24, 2016
Treating HIV-1 infection with dendritic cells.
Nancy C Connolly1, Bonnie A Colleton, Charles R Rinaldo
1University of Pittsburgh, School of Medicine and Graduate School of Public Health, 204 Craft Avenue, B501, Pittsburgh, PA 15213, USA. nconnolly@mail.magee.edu
Current Opinion in Molecular Therapeutics
|August 19, 2007
Summary
Dendritic cells (DCs) are crucial for immune responses but are targeted by HIV-1. This review explores HIV-1-DC interactions and DC-based therapies for HIV-1 infection.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Dendritic cells (DCs) orchestrate immune responses, making them targets for pathogens like HIV-1.
- HIV-1 primarily affects the immune system, highlighting the need to understand DC interactions.
- Research on DC function and HIV-1 interactions is rapidly advancing.
Purpose of the Study:
- To review the complex interactions between HIV-1 and dendritic cells (DCs).
- To examine the impact of these interactions on developing DC-based therapeutics for HIV-1.
- To summarize the current state of DC-based therapeutic vaccines for HIV-1 infection.
Main Methods:
- Literature review of scientific publications on HIV-1 and DC interactions.
- Analysis of existing data on DC function in the context of HIV-1 infection.
- Synthesis of information regarding therapeutic strategies involving DCs for HIV-1.
Main Results:
- Pathogens, including HIV-1, exploit DCs to evade host immunity.
- Understanding HIV-1-DC interactions is key to developing effective immunotherapies.
- DC-based therapeutic vaccines show promise for treating HIV-1 infection.
Conclusions:
- Targeting DCs offers a promising strategy to counteract HIV-1's effects on the immune system.
- Further research into HIV-1-DC interactions will refine DC-based therapeutic approaches.
- DC-based vaccines represent a dynamic area of development for HIV-1 treatment.
Related Concept Videos
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...